TWO NEW KLRI PEER-REVIEWED PUBLICATIONS: Hormone Therapy May Reduce Atherosclerosis in Women Close to Menopause; Growth Hormone May Increase Risk of Diabetes, Improve Lipid Profile in Men
PHOENIX, Aug. 3 /PRNewswire-USNewswire/ -- The Phoenix-based Kronos Longevity Research Institute (KLRI) has published two new publications on hormone therapies and their effects on reducing the risks of cardiovascular disease in older adults.
Cardiovascular disease caused by ...
Popular Breast Cancer Drug Used with Certain Antidepressants Puts New Jersey Women at Risk
FRANKLIN LAKES, N.J., July 30 /PRNewswire-FirstCall/ -- A new analysis finds that
women in New Jersey who take the breast cancer drug tamoxifen in conjunction with certain popular antidepressants may be at a higher risk for a breast cancer recurrence.
In May, Medco Health Solutions, ...
Economy is Driving Many Osteoporotic Women to Retire Later - But Their Ability to Work May Be Undermined by Sub-Optimal Management of Their Disease
CLEVELAND, July 28 /PRNewswire/ -- More than 340,000(2)
women suffer from postmenopausal osteoporosis (PMO) in Ohio and more than 900,000(3) are at risk for the disease. According to a census report on the prevalence of osteoporosis, the number of
women suffering from the...
New Study: Antidepressants Commonly Prescribed with Tamoxifen Put Women at Much Higher Risk for Recurrent Breast Cancer
- Several SSRIs more than double risk of cancer recurrence in tamoxifen treated patients
- Nearly 30 percent of tamoxifen users take drugs that reduce its effectiveness against breast cancer
ORLANDO, Fla., May 30 /PRNewswire-FirstCall/ -- An important new study finds that certain popula...
CVS Caremark Data Confirms Improved Outcomes for Women with Osteoporosis Who are Adherent to Therapy
Non-adherent
women up to six times more likely to experience a fracture
WOONSOCKET, R.I., May 11 /PRNewswire/ -- Data released today by CVS Caremark (NYSE: CVS ) indicates that 87 percent of
women 18 years and older with osteoporosis, who were taking a drug therapy to treat the disease, di...
Interleukin Genetics Presents Research Linking Vertebral Fractures to Gene Variations in Asian Women With Osteoporosis
WALTHAM, Mass., April 1 /PRNewswire-FirstCall/ -- Interleukin Genetics, Inc. (NYSE Amex: ILI ), announced today that the company will present research findings from a large clinical study on the genetics of osteoporosis and vertebral fractures at the 8th International Symposium on Osteoporosis...
QuatRx Completes Enrollment of Ophena(TM)(Ospemifene Tablets) Final Pivotal Phase 3 Study in Women with Postmenopausal Vaginal Atrophy
ANN ARBOR, Mich., March 31 /PRNewswire/ -- QuatRx Pharmaceuticals, a privately-held biopharmaceutical company, today announced that it has completed enrollment in the Company's second pivotal Phase 3 clinical trial of Ophena(TM) (ospemifene tablets). Together with the previously completed firs...
Phase III Trial Showed Investigational Compound Arzoxifene Was Superior to Evista(R) (raloxifene HCl) in Increasing BMD in Postmenopausal Women with Osteoporosis
Results from the "NEXT" Study Also Showed Arzoxifene Significantly Suppressed Bone Turnover Markers versus Raloxifene in Postmenopausal
Women with Osteoporosis
ATHENS, Greece, March 23 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY ) presented new data showing arzoxifene, an inv...
Children's Hospital Receives $6.7 Million Grant From Gates Foundation to Study Influenza Vaccine in Pregnant Women in Asia
CINCINNATI, Feb. 24 /PRNewswire-USNewswire/ -- Cincinnati Children's Hospital Medical Center has received a $6.7 million grant from the Bill & Melinda Gates Foundation to help prevent flu in pregnant
women and their infants in rural areas around the world.
Most childhood deaths occur in...
Risk of Stroke, Heart Disease in Women Lowered by Mediterranean Diet
BOSTON, Feb. 17 /PRNewswire-USNewswire/ --
Women who adhere to a traditional Mediterranean diet -- high in monounsaturated fat, plant proteins, whole grains and fish -- are at a lower risk for stroke and coronary heart disease, according to a study published this week in Circulation: Journal ...
Pivotal Data Published For First Biomarker Combination Test to Determine Risk of Ovarian Cancer in Women Who Present With Pelvic Mass
Article in Gynecologic Oncology Supports Use of Fujirebio Diagnostics'
HE4 Test with CA125 for Risk Stratification of
Women with Suspected Ovarian Cancer
MALVERN, Pa., Jan. 26 /PRNewswire/ -- A pivotal clinical trial published in the January 2009 issue of the journal Gynecologic Oncology ...
Cardiac Disease in Women Remains Untreated for Decades
Though HCM Symptoms Identified, Versus Men
NEW YORK, Jan. 26 /PRNewswire-USNewswire/ -- Hypertrophic Cardiomyopathy (HCM) is a genetic heart disease that creates a thickening of the heart wall muscle and is the leading cause of sudden cardiac death in children and young adults (<40). More...
New International Study Shows Women With Symptomatic Fibroids Delaying Treatment Despite Substantial Burden on Quality of Life
One in five
women suffer from fibroid symptoms at least 5 years before
seeking treatment.
LAS VEGAS, Oct. 29 /PRNewswire/ -- At the annual meeting of the
American Association of Gynecologic Laparoscopists (AAGL), ETHICON Women's
Health & Urology today announced results of a seven-country stu...
Young Women Diagnosed with Early-Stage Breast Cancer More Likely to Die than Older Women
SAN FRANCISCO, Oct. 15 /PRNewswire-USNewswire/ -- In a national study
presented earlier today at the 2008 American College of Surgeons (ACS)
Clinical Congress, a researcher reported that "women under 40 years of age
diagnosed with Stage I breast cancer are 44 percent more likely to die than
ol...
New Analyses Indicate that Divigel(R) (estradiol gel) 0.1% Is a Valuable Option for Certain Postmenopausal Women With Hot Flashes
- Transdermal Estrogen Analyses Continue to Show Benefits of Hormone Therapy Use in Menopausal
Women -
MAPLE GROVE, Minn., Sept. 25 /PRNewswire/ -- Upsher-Smith Laboratories,
Inc. today announced that clinical abstracts featuring Divigel(R)
(estradiol gel) 0.1% were present...
What is the Optimal Method of Ischemia Evaluation in WomeN: Preliminary Data from the WOMEN Study
BOSTON, Sept. 13 /PRNewswire-USNewswire/ -- Cardiovascular disease
kills more
women each year than all cancers combined. Although this
statistic is gaining more recognition among physicians and patients, the
unique risk factors and symptoms of female patients make diagnosis and
prognosis of wo...
QuatRx Initiates Second Phase 3 Study of Ophena(TM) (Ospemifene Tablets) in Women With Postmenopausal Vaginal Syndrome
Pivotal Study Seeks to Enroll 750
Women at More Than 100 Sites in the U.S.
ANN ARBOR, Mich., Sept. 4 /PRNewswire/ -- QuatRx Pharmaceuticals, a
privately-held biopharmaceutical company focused on development and
commercialization of compounds to treat endocrine, metabolic and
cardiovascular diso...
Going Beyond 'Spa Day': Giving Women the Opportunity to Do Something Proactive Which May Lead to Long Term Health Benefits
C'elle Discovers Stem Cells Found in Menstrual Blood May Offer Long-Lasting Therapeutic Effects for Time-Pressed Women
OLDSMAR, Fla., Aug. 25 /PRNewswire/ -- Time. It is a precious
commodity. Yet most
women would agree that there never seems to be enough
of it. And the small amount...
New Research Just Released: Women Can Now Safely Postpone Motherhood Until Time Is Right
ATLANTA, June 23 /PRNewswire/ -- For
women who would like to have
children but who have not yet found the right partner or the right time in
their lives, the door to a new option has opened wide.
Research now shows an advanced egg-freezing technique known as
vitrification, a quick freezing m...
Ending Cervical Cancer Featured at Summit; QIAGEN CEO Issues a Call to Global Women Leaders
HANOI, Vietnam, June 6 /PRNewswire-FirstCall/ -- QIAGEN was featured
this week for its efforts to eliminate cervical cancer at the 14th annual
Global Summit of
Women in Hanoi, Vietnam. CEO Peer Schatz came to this
prominent international platform to issue a call to other leaders in
business, N...
Video: Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa(R) in Women With Early-Stage Breast Cancer
- Zometa when added to hormone therapy, following surgery, significantly reduced the risk of cancer returning or death by 36% beyond clinical benefits achieved with hormone therapy alone(1) - Findings may allow clinicians to improve standard of care for
premenopausal
women diagn...
FDA Clears ExAblate Fertility Enhancement Study in Women With Uterine Fibroids
TIRAT CARMEL, Israel, May 28 /PRNewswire/ --
- Study Will Compare Birth Rates of
Women who Underwent Non-Invasive
MRgFUS to Those who had Invasive Fibroid Surgery
InSightec Ltd. announced today that the U.S. Food and Drug
Administration (FDA) cleared the company to conduct a clinical trial...
New AMITIZA 8 mcg Phase III Studies Demonstrated Overall Symptom Improvement in Adult Women with Irritable Bowel Syndrome with Constipation (IBS-C)
Additional Digestive Disease Week data highlight effects of AMITIZA in patients with IBS-C
SAN DIEGO, May 18 /PRNewswire/ -- New study results indicated that
treatment with AMITIZA(R) (lubiprostone) 8 mcg lead to significant relief
of overall symptoms of Irritable Bow...
Adding Breast Ultrasound Screening to Mammography Reveals Cancers not Seen on Mammography Alone in Women at Increased Risk for Breast Cancer
PHILADELPHIA, May 13 /PRNewswire-USNewswire/ -- In
women at increased
risk for breast cancer, adding a screening ultrasound examination to
routine mammography revealed 28 percent more cancers than mammography
alone. However, the additional ultrasound exam substantially increased the
rates of f...
Pregnant Women Need Omega-3 to Boost Infant Development
GORDONSVILLE, Va., April 21 /PRNewswire/ -- A new study funded by
Health Canada and other organizations has proven a direct correlation
between dietary consumption of the omega-3 DHA* and enhanced infant
development. The study, which was supervised by Universite Laval
researchers and published...
Vermillion's Biomarkers Prove Beneficial in Identifying Women With Ovarian Cancer and Detecting Early-Stage Disease
- Multiple Studies Presented at Society of Gynecologic Oncologists' Annual Meeting on Women's Cancer -
FREMONT, Calif. and TAMPA, Fla., March 10 /PRNewswire-FirstCall/ --
Vermillion, Inc. (Nasdaq: VRMLD ), a molecular diagnostics company,
presented data from several studie...
Huge Drop in Preterm Birth-Risk Among Women Taking Folic Acid One Year Before Conception
Largest U.S. Study of Pre-conceptional Folic Acid Supplementation
Receives March of Dimes Award
DALLAS, Jan. 31 /PRNewswire-USNewswire/ -- New research suggests that
women who take folic acid supplements for at least one year before they
become pregnant can cut their risk of having a prema...
Pilot Study Opens the Door for Avastin Use in Curative Setting for Women With Breast Cancer
Roche in collaboration with Genentech commit to large phase III adjuvant clinical programme set to unlock Avastin's potential in early breast
SAN ANTONIO, Dec. 17 /PRNewswire/ -- According to new phase II study
data, Avastin (bevacizumab) can proceed to be tested after breast cancer
surgery i...
Enrollment of Women in Cardiovascular Trials Fails to Meet Current Federal Mandates
Cleveland Clinic Researchers Highlight the Need For More
Women to Participate in Clinical Trials
ORLANDO, Fla., Nov. 6 /PRNewswire-USNewswire/ -- Cleveland Clinic
researchers have recently found that
women remain a significant minority in
cardiovascular randomized contro...
Most Women With HIV and Their Health Care Providers Have Not Discussed How HIV Might Affect Them Differently Than Men
Survey Shows Nearly Three-Quarters of
Women Struggle in Managing Their Daily Lives
ATLANTA, Oct. 10 /PRNewswire/ -- New findings from the
Women Living
Positive survey show a communication gap between
women living with HIV and
their health care providers when it co...
Spit for the Cure Offers Unique Opportunity for Women to Participate in Breast Cancer Research
LITTLE ROCK, Ark., Oct. 8 /PRNewswire-USNewswire/ -- A research study
at the University of Arkansas for Medical Sciences (UAMS) is designed to
establish one of the largest and most rapidly assembled groups of
women to
aid in the study of breast cancer occurrence. Spit for the Cure involves th...
Bay Area Women Sought for Egg Freezing Study
Reproductive Science Center of the San Francisco Bay research seeks couples with male factor infertility
SAN RAMON, Calif., Sept. 28 /PRNewswire/ -- Reproductive Science Center
of the San Francisco Bay Area, in cooperation with ViaCell, Inc., has been
awarded a research gran...
New Study Shows Once-Monthly Boniva(R) is as Clinically Effective as Once-Weekly Fosamax(R) at Increasing Bone Mineral Density in Postmenopausal Women With Osteoporosis
HONOLULU, Sept. 19 /PRNewswire/ --
Women with postmenopausal
osteoporosis receiving once-monthly Boniva(R) (ibandronate sodium) achieved
clinically comparable increases in bone mineral density (BMD) to those
receiving once-weekly Fosamax(R) (alendronate sodium), according to a new
study presen...
Risedronate Reduced Risk of Fracture Among Osteoporotic Postmenopausal Women with History of Hip Fracture
HONOLULU, Sept. 17 /PRNewswire-FirstCall/ -- In a new analysis reported
at the American Society for Bone and Mineral Research (ASBMR) 29th Annual
Meeting, risedronate 5 mg decreased clinical fracture risk by 50% over
three years relative to placebo in a group of postmenopausal
women with
osteo...
Cell Therapeutics, Inc. (CTI) Supports Panel Discussion on Women and Lung Cancer on Capitol Hill
Event for Congressional Members and Staff Will Focus on Advances in Research and Treatment of Lung Cancer in Women
SEATTLE, Sept. 14 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc.
(CTI) (Nasdaq: CTIC; MTAX:), along with the Society for Women's Health
Research, the Lung Cancer ...
Cell Therapeutics, Inc. (CTI) Sponsors Panel Discussion on Women and Lung Cancer on Capitol Hill
Event for Congressional Members and Staff Will Focus on Advances in Research and Treatment of Lung Cancer in Women
SEATTLE, Sept. 14 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc.
(CTI) (Nasdaq: CTIC; MTAX:), along with the Society for Women's Health
Research, the Lung Cancer ...
European Experts Recommend Pregnant and Nursing Women Take More DHA - Every Day
Women Who Take DHA Have Healthier Pregnancies, Fewer Premature Births
GORDONSVILLE, Va., Aug. 29 /PRNewswire/ -- More than 50 nutritional
experts from a European Union (EU) committee now recommend pregnant and
nursing
women supplement their diets on a daily basis with a large amount
of DHA, a...
QuatRx Completes Patient Enrollment in Phase 3 Study of Ophena(TM) in Women with Postmenopausal Vaginal Syndrome
Multicenter Study Enrolls More Than 800
Women to Evaluate QuatRx's New-Generation Selective Estrogen Receptor Modulator (SERM)
ANN ARBOR, Mich., Aug. 22 /PRNewswire/ -- QuatRx Pharmaceuticals, a
privately-held biopharmaceutical company focused on development and
commercialization of co...
Progesterone Therapy and Preterm Birth: More Evidence Helps Identify Women Who Can Benefit
WHITE PLAINS, N.Y., AUG. 2 /PRNewswire-USNewswire/ -- Two major studies
published today in The New England Journal of Medicine can help doctors
better identify pregnant
women at risk for preterm delivery who can benefit
from progesterone treatment, the March of Dimes Foundation said today. In...
Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
- Shown to be highly effective in strengthening bones and protecting against osteoporosis-related fractures, including spine and hip
- Reclast reduced spine fractures by 70% and hip fractures by 41% compared to placebo in study published in New England Journal of Medicine
- Unique once...